News & Sentiment
CrowdStrike stock rises after bullish analyst calls
CrowdStrike CRWD shares gained about 1.1% in trading on Tuesday after receiving fresh support from Wall Street, with Loop Capital initiating coverage on the cybersecurity company with a Buy rating and Cantor Fitzgerald reiterating its bullish stance. Loop Capital analyst Yun Kim assigned a $230...
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
1,933 articles
📰
Pacific Biosciences of California (PACB) Laps the Stock Market: Here's Why
Pacific Biosciences of California (PACB) reached $1.39 at the closing of the latest trading day, reflecting a +2.21% change compared to its last...
Le club de football NASSR FC et HUMAIN annoncent un partenariat stratégique historique
Cet accord de grande envergure regroupe un partenariat de premier plan pour le maillot, les droits d'appellation du nouveau centre d'entraînement du...
📰
Jushi Holdings Inc. (JUSHF) Reports Q2 Loss, Tops Revenue Estimates
Jushi Holdings Inc. (JUSHF) delivered earnings and revenue surprises of +33.33% and +5.86%, respectively, for the quarter ended June 2026. Do the...
📰
Jushi Holdings Inc. (JUSHF) Reports Q2 Loss, Tops Revenue Estimates
Jushi Holdings Inc. (JUSHF) delivered earnings and revenue surprises of +33.33% and +5.86%, respectively, for the quarter ended June 2026. Do the...
📰
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today
In the latest trading session, DaVita HealthCare (DVA) closed at $239.46, marking a +1.33% move from the previous day.
📰
Chemed (CHE) Tops Q2 Earnings and Revenue Estimates
Chemed (CHE) delivered earnings and revenue surprises of +9.19% and +1.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues...
📰
Chemed (CHE) Tops Q2 Earnings and Revenue Estimates
Chemed (CHE) delivered earnings and revenue surprises of +9.19% and +1.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues...
📰
Acadia Healthcare (ACHC) Surpasses Q2 Earnings and Revenue Estimates
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of +15.15% and +2.50%, respectively, for the quarter ended June 2026. Do the...
📰
Why Cardinal Health (CAH) Outpaced the Stock Market Today
In the most recent trading session, Cardinal Health (CAH) closed at $232.51, indicating a +1.38% shift from the previous trading day.
📰
Acadia Healthcare (ACHC) Surpasses Q2 Earnings and Revenue Estimates
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of +15.15% and +2.50%, respectively, for the quarter ended June 2026. Do the...
📰
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts
Humacyte, Inc. (HUMA) concluded the recent trading session at $0.63, signifying a -6.44% move from its prior day's close.
📰
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $490.39, moving +2.38% from the previous trading session.
📰
Gilead Sciences (GILD) Laps the Stock Market: Here's Why
Gilead Sciences (GILD) reached $134.32 at the closing of the latest trading day, reflecting a +2.91% change compared to its last close.
📰
Why Opko Health Stock Surged by 33% on Tuesday
It posted a beat-and-raise second quarter.
📰
Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing
In the most recent trading session, Pfizer (PFE) closed at $25.25, indicating a +2.35% shift from the previous trading day.
📰
Novo Nordisk (NVO) Surpasses Market Returns: Some Facts Worth Knowing
Novo Nordisk (NVO) reached $50.96 at the closing of the latest trading day, reflecting a +2.6% change compared to its last close.
📰
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $29.32, indicating a -3.04% shift from the previous trading day.
📰
CVS Health (CVS) Laps the Stock Market: Here's Why
CVS Health (CVS) closed the most recent trading day at $109.34, moving +2.12% from the previous trading session.
📰
Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, Novavax (NVAX) closed at $7.37, indicating a -1.6% shift from the previous trading day.
📰
Eli Lilly (LLY) Rises Higher Than Market: Key Facts
Eli Lilly (LLY) closed the most recent trading day at $1, moving +2.09% from the previous trading session.
These 3 Companies Reported Record Results and Raised Guidance
Abbott Laboratories, Taiwan Semiconductor, and Johnson & Johnson have all delivered strong earnings releases in the Q2 cycle, with each breaking...
📰
NANO-X DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NNOX
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nano-X...
These 3 Companies Reported Record Results and Raised Guidance
Abbott Laboratories, Taiwan Semiconductor, and Johnson & Johnson have all delivered strong earnings releases in the Q2 cycle, with each breaking...
📰
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and...
📰
BOARDWALK REIT AND DGAM CANADIAN PRIVATE REAL ESTATE FUND, L.P. ANNOUNCE STRATEGIC CO-OWNERSHIP TO EXPAND WESTERN CANADIAN MULTIFAMILY PLATFORM AND INITIAL $292 MILLION SEED PORTFOLIO
CALGARY, AB, July 28, 2026 /PRNewswire/ -- Boardwalk Real Estate Investment Trust ("Boardwalk", the "REIT" or the "Trust") (TSX: BEI.UN) and DGAM...
📰
United Therapeutics CEO Sells $5 Million of Shares. What Does This Mean for Investors?
Martine Rothblatt exercised options at $135.42 and sold at $530.42 under a pre-established Rule 10b5-1 plan, reducing her stake by just 1% while...
📰
Wall Street Says Buy the Dip in Viking Therapeutics. Here's the Bull Case
The stock looks like a high-risk, high-reward play.
📰
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market MarketWatch
Martin Madaus Elected to Haemonetics Board of Directors
BOSTON, July 28, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) a global medical technology company focused on delivering innovative...
📰
Chemed Reports Second-Quarter 2026 Results
Chemed reports Q2 2026 results and increases full year guidance.
📰
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic...
📰
Jushi Holdings Inc. Reports Second Quarter 2026 Financial Results
Revenue Increased 10% Year-over-Year to $71.3 million, Reflecting Growth Across Both Retail and Wholesale Channels